115 related articles for article (PubMed ID: 1563831)
21. Theophylline induced differentiation provides direct evidence for the deregulation of c-myc in Burkitt's lymphoma and suggests participation of immunoglobulin enhancer sequences.
Sandlund JT; Neckers LM; Schneller HE; Woodruff LS; Magrath IT
Cancer Res; 1993 Jan; 53(1):127-32. PubMed ID: 8416737
[TBL] [Abstract][Full Text] [Related]
22. The association of c-myc rearrangements with specific types of human non-Hodgkin's lymphomas.
Van Krieken JH; Kluin PM
Leuk Lymphoma; 1992 Aug; 7(5-6):371-6. PubMed ID: 1493439
[TBL] [Abstract][Full Text] [Related]
23. CAD, a c-Myc target gene, is not deregulated in Burkitt's lymphoma cell lines.
Mac SM; Farnham PJ
Mol Carcinog; 2000 Feb; 27(2):84-96. PubMed ID: 10657901
[TBL] [Abstract][Full Text] [Related]
24. Gene expression profiling reveals different pathways related to Abl and other genes that cooperate with c-Myc in a model of plasma cell neoplasia.
Park ES; Shaughnessy JD; Gupta S; Wang H; Lee JS; Woo HG; Zhan F; Owens JD; Potter M; Janz S; Mushinski JF
BMC Genomics; 2007 Aug; 8():302. PubMed ID: 17764563
[TBL] [Abstract][Full Text] [Related]
25. Role of bcl-X(L) in the control of apoptosis in murine myeloma cells.
Gauthier ER; Piché L; Lemieux G; Lemieux R
Cancer Res; 1996 Mar; 56(6):1451-6. PubMed ID: 8640839
[TBL] [Abstract][Full Text] [Related]
26. Effects of sodium butyrate on the rearranged c-myc expression in mouse plasmacytoma cells.
Kondoh N; Oikawa T; Satoh C; Kuzumaki N
Exp Cell Res; 1991 Sep; 196(1):146-9. PubMed ID: 1879469
[TBL] [Abstract][Full Text] [Related]
27. Specific expression of cellular oncogenes c-myc and c-myb in T-cell lines established from three types of bovine lymphosarcomas.
Ishiguro N; Matsui T; Shinagawa M
Am J Vet Res; 1993 Dec; 54(12):2010-4. PubMed ID: 8116930
[TBL] [Abstract][Full Text] [Related]
28. A new variant 15; 16 translocation in mouse plasmacytoma leads to the juxtaposition of c-myc and immunoglobulin lambda.
Axelson H; Panda CK; Silva S; Sugiyama H; Wiener F; Klein G; Sumegi J
Oncogene; 1991 Dec; 6(12):2263-70. PubMed ID: 1766673
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of myc, max and RB1 genes in human gliomas and glioma cell lines.
Hirvonen HE; Salonen R; Sandberg MM; Vuorio E; Västrik I; Kotilainen E; Kalimo H
Br J Cancer; 1994 Jan; 69(1):16-25. PubMed ID: 8286200
[TBL] [Abstract][Full Text] [Related]
30. Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma.
Affer M; Chesi M; Chen WG; Keats JJ; Demchenko YN; Roschke AV; Van Wier S; Fonseca R; Bergsagel PL; Kuehl WM
Leukemia; 2014 Aug; 28(8):1725-1735. PubMed ID: 24518206
[TBL] [Abstract][Full Text] [Related]
31. Extinction of expression of the translocated myc gene in somatic cell hybrids between mouse myeloma and L-cells.
Greenberg A; Hijazzi M; Sharir H; Cohen L; Bergman Y; Ber R; Laskov R
Int J Cancer; 1989 Jan; 43(1):87-92. PubMed ID: 2492015
[TBL] [Abstract][Full Text] [Related]
32. Expression of myc family oncoproteins in small-cell lung-cancer cell lines and xenografts.
Rygaard K; Vindeløv LL; Spang-Thomsen M
Int J Cancer; 1993 Apr; 54(1):144-52. PubMed ID: 8386707
[TBL] [Abstract][Full Text] [Related]
33. Expression of the L-myc gene is under positive control by short-lived proteins.
Saksela K
Oncogene; 1987; 1(3):291-6. PubMed ID: 2838780
[TBL] [Abstract][Full Text] [Related]
34. C-MAF oncogene dysregulation in multiple myeloma: frequency and biological relevance.
Rasmussen T; Knudsen LM; Dahl IM; Johnsen HE
Leuk Lymphoma; 2003 Oct; 44(10):1761-6. PubMed ID: 14692531
[TBL] [Abstract][Full Text] [Related]
35. Regressing nude mouse grafts of Burkitt's lymphoma x lymphoblastoid cell hybrids show deregulation of the c-myc gene and expression of the EBV latent membrane protein.
Wolf J; Klevenz B; Pawlita M; Komitowski D; Moldenhauer G; zur Hausen H
Int J Cancer; 1991 Jan; 47(1):99-104. PubMed ID: 1702406
[TBL] [Abstract][Full Text] [Related]
36. Identification of c-myc promoter-binding protein and X-box binding protein 1 as interleukin-6 target genes in human multiple myeloma cells.
Wen XY; Stewart AK; Sooknanan RR; Henderson G; Hawley TS; Reimold AM; Glimcher LH; Baumann H; Malek LT; Hawley RG
Int J Oncol; 1999 Jul; 15(1):173-8. PubMed ID: 10375612
[TBL] [Abstract][Full Text] [Related]
37. L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer.
Nau MM; Brooks BJ; Battey J; Sausville E; Gazdar AF; Kirsch IR; McBride OW; Bertness V; Hollis GF; Minna JD
Nature; 1985 Nov 7-13; 318(6041):69-73. PubMed ID: 2997622
[TBL] [Abstract][Full Text] [Related]
38. Differences between Burkitt's lymphomas and mouse plasmacytomas in the immunoglobulin heavy chain/c-myc recombinations that occur in their chromosomal translocations.
Müller JR; Janz S; Potter M
Cancer Res; 1995 Nov; 55(21):5012-8. PubMed ID: 7585544
[TBL] [Abstract][Full Text] [Related]
39. c-myc expression correlates with suppression of c-kit protooncogene expression in small cell lung cancer cell lines.
Plummer H; Catlett J; Leftwich J; Armstrong B; Carlson P; Huff T; Krystal G
Cancer Res; 1993 Sep; 53(18):4337-42. PubMed ID: 7689933
[TBL] [Abstract][Full Text] [Related]
40. Amplification and expression of the c-myc oncogene in human lung cancer cell lines.
Little CD; Nau MM; Carney DN; Gazdar AF; Minna JD
Nature; 1983 Nov 10-16; 306(5939):194-6. PubMed ID: 6646201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]